SAREPTA THERAPEUTICS, INC. Payments for Restructuring
SAREPTA THERAPEUTICS, INC. (SRPT) reported Payments for Restructuring of $711.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2019-02-28
- SAREPTA THERAPEUTICS, INC. payments for restructuring for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. payments for restructuring for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. payments for restructuring for the quarter ending 2018-06-30 was $356.00K, a 21.93% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. payments for restructuring for the quarter ending 2018-03-31 was $355.00K, a 9.90% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. payments for restructuring for fiscal 2018 was $711.00K, a 57.55% decline from fiscal 2017.
- SAREPTA THERAPEUTICS, INC. payments for restructuring for fiscal 2017 was $1.68M, a 18.81% decline from fiscal 2016.
- SAREPTA THERAPEUTICS, INC. payments for restructuring for fiscal 2016 was $2.06M.
- SAREPTA THERAPEUTICS, INC. payments for restructuring for fiscal 2014 was $58.00K, a 93.59% decline from fiscal 2013.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $356.00K derived: sum of 3 quarters · filed 2019-02-28 | $711.00K 10-K · filed 2019-02-28 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $356.00K derived: sum of 2 quarters · filed 2018-10-31 | $711.00K 10-Q · filed 2018-10-31 | $1.07M derived: sum of 4 quarters · filed 2019-02-28 |
| 2018-06-30 | $356.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $711.00K 10-Q · filed 2018-08-08 | $1.07M derived: sum of 3 quarters · filed 2019-02-28 | $1.54M derived: sum of 4 quarters · filed 2019-02-28 |
| 2018-03-31 | $355.00K 10-Q · filed 2018-05-03 | $712.00K derived: sum of 2 quarters · filed 2019-02-28 | $1.18M derived: sum of 3 quarters · filed 2019-02-28 | $1.64M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-12-31 | $357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $825.00K derived: sum of 2 quarters · filed 2019-02-28 | $1.28M derived: sum of 3 quarters · filed 2019-02-28 | $1.68M 10-K · filed 2019-02-28 |
| 2017-09-30 | $468.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $924.00K derived: sum of 2 quarters · filed 2017-11-01 | $1.32M 10-Q · filed 2017-11-01 | $2.37M derived: sum of 4 quarters · filed 2018-03-01 |
| 2017-06-30 | $456.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $850.00K 10-Q · filed 2017-08-03 | $1.90M derived: sum of 3 quarters · filed 2018-03-01 | $2.36M derived: sum of 4 quarters · filed 2018-03-01 |
| 2017-03-31 | $394.00K 10-Q · filed 2017-05-04 | $1.45M derived: sum of 2 quarters · filed 2018-03-01 | $1.90M derived: sum of 3 quarters · filed 2018-03-01 | $2.46M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.51M derived: sum of 2 quarters · filed 2018-03-01 | $2.06M derived: sum of 3 quarters · filed 2018-03-01 | $2.06M 10-K · filed 2018-03-01 |
| 2016-09-30 | $458.00K 10-Q · filed 2016-11-07 | $1.01M derived: sum of 2 quarters · filed 2016-11-07 | $1.01M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $553.00K 10-Q · filed 2016-08-09 | $553.00K 10-Q · filed 2016-08-09 | ||
| 2014-12-31 | $58.00K 10-K · filed 2015-02-26 | |||
| 2014-03-31 | $8.00K 10-Q · filed 2014-05-08 | $92.00K derived: sum of 2 quarters · filed 2015-02-26 | $210.00K derived: sum of 3 quarters · filed 2015-02-26 | $712.00K derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-12-31 | $84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $202.00K derived: sum of 2 quarters · filed 2015-02-26 | $704.00K derived: sum of 3 quarters · filed 2015-02-26 | $905.00K 10-K · filed 2015-02-26 |
| 2013-09-30 | $118.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $620.00K derived: sum of 2 quarters · filed 2013-11-12 | $821.00K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $502.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $703.00K 10-Q · filed 2013-08-08 | ||
| 2013-03-31 | $201.00K 10-Q · filed 2014-05-08 | |||
| 2012-12-31 | $828.00K 10-K · filed 2015-02-26 | |||
| 2011-12-31 | $317.00K 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |